Lymphatic Malformations

2021 ◽  
pp. 491-497
Author(s):  
Kasturi Bhattacharjee ◽  
Nirod Medhi ◽  
Shyam Sundar Das Mohapatra
Author(s):  
Zhi-Min Lei ◽  
Xing-Xing Huang ◽  
Zhi-Jun Sun ◽  
Wen-Feng Zhang ◽  
Yi-Fang Zhao

2021 ◽  
Vol 60 (1) ◽  
pp. 13-19 ◽  
Author(s):  
Yu-Peng Liu ◽  
Yen-Lin Huang ◽  
Pei-Shan Tsai ◽  
Dao-Chen Lin ◽  
Chih-Ping Chen

2020 ◽  
Vol 16 (1) ◽  
Author(s):  
Moaied A. Hassan ◽  
Hasan K. Gatea ◽  
Thura K. Ja’afar

Abstract Background Lymphatic malformations are rare benign cystic tumors that result from localized disordered embryologic development of the lymphatic system and can develop anywhere in the body, predominantly in the head and neck. These lesions are classified according to the diameter of the largest cystic cavity within the lesion into microcystic and macrocystic types. Historically, surgical excision has been considered the mainstay of treatment and still remains the first therapeutic option of choice for many surgeons particularly for giant macrocystic lesions. Several alternative therapeutic modalities emerged including intralesional sclerotherapy and laser therapy with encouraging results. The study is designed to assess the effectiveness and safety of surgical excision as an initial therapeutic option in the management of these malformations. Results Asymptomatic mass with parental cosmetic and functional concerns was the mode of presentation in six (66.7%) patients. Seven (77.8%) patients were presented before the age of 2 years. Six (66.7%) of the patients had their lesions in the neck. Complete surgical excision was achieved in eight (88.9%) patients without any evident significant injury to vital neurovascular structures. None of the patients had any difficulties with breathing, swallowing, or phonation and cosmetic results were satisfactory in the majority (88.9%) of them. Conclusion Radical surgical excision of giant macrocystic lymphatic malformations in children is possible in experienced hands. It is an effective and safe initial therapeutic option and gives satisfactory esthetic and functional results.


2021 ◽  
pp. 195-201
Author(s):  
Emily Sideris ◽  
Er Tsing Vivian Tng ◽  
Paul Chee

We present a rare case of KRAS keratinocytic epidermal nevus syndrome with lymphatic malformation, responsive to treatment with sirolimus, an mTOR inhibitor. A brief review of the current literature regarding sirolimus use in vascular malformations, lymphatic malformations, regional overgrowth syndromes, and RASopathies is discussed.


2020 ◽  
Vol 36 (9) ◽  
pp. 1047-1054
Author(s):  
Hidehito Usui ◽  
Masato Shinkai ◽  
Norihiko Kitagawa ◽  
Kyoko Mochizuki ◽  
Issei Kawakita ◽  
...  

2011 ◽  
Vol 53 (1) ◽  
pp. 150-155 ◽  
Author(s):  
Yaowu Yang ◽  
Moyi Sun ◽  
Qin Ma ◽  
Xiaobing Cheng ◽  
Jianhua Ao ◽  
...  

Author(s):  
Paolo Gasparella ◽  
Besiana P. Beqo ◽  
Emir Q. Haxhija ◽  
Castellani Christoph ◽  
Christoph Arneitz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document